Development of a new purified vero cell rabies vaccine (Rabivax-S) at the serum institute of India Pvt Ltd

Development of a new purified vero cell rabies vaccine (Rabivax-S) at the serum institute of India Pvt Ltd

Introduction: Rabies is a 100% fatal disease with significant disease burden in Asia and Africa but preventable with vaccines and immunoglobulins. There are very few WHO prequalified cell culture derived rabies vaccines available globally for use in humans. We have developed a new purified vero cell...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Prasad S. Kulkarni, Ashish Sahai, Bhagwat Gunale, Rajeev M Dhere
Formaat:	Artikel
Taal:	English
Gepubliceerd in:	Taylor & Francis Group 2017-04-01
Reeks:	Expert Review of Vaccines
Onderwerpen:	rabivax-s rabies purified vero cell rabies vaccine safety immunogenicity
Online toegang:	http://dx.doi.org/10.1080/14760584.2017.1294068

Gelijkaardige items

Immunogenicity and safety of WHO-approved TRC-ID regimen with a chromatographically purified Vero cell rabies vaccine with or without rabies immunoglobulin in children
door: Piyada Angsuwatcharakon, et al.
Gepubliceerd in: (2018-02-01)

Safety and immunogenicity of freeze-dried human rabies vaccines: A phase 3 clinical trial of Zagreb and Essen regimes
door: Jia Li, et al.
Gepubliceerd in: (2024-12-01)

Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine
door: D.J. Briggs, et al.

Immunogenicity and safety of purified vero cell rabies vaccine (PVRV) produced by Liaoning Cheng Da Co. under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese adults aged 50 and above
door: Jing Wang, et al.
Gepubliceerd in: (2017-01-01)

DETERMINATION OF THE RABIES VIRUS-INFECTED VERO LINE CELL PORTION BY FLOW CYTOMETRY
door: A. L. Kravtsov, et al.
Gepubliceerd in: (2019-08-01)

A phase 3 clinical trial on the immunogenicity and safety of booster vaccination after Zagreb or Essen regimens
door: Hua-Kun Lv, et al.
Gepubliceerd in: (2025-02-01)

Post-exposure prophylaxis (PEP) for rabies with purified chick embryo cell vaccine: a systematic literature review and meta-analysis
door: Scott Preiss, et al.
Gepubliceerd in: (2018-06-01)

Study on immune persistence of the CTN-1V strain rabies vaccine in humans
door: Lidong Wang, et al.
Gepubliceerd in: (2024-03-01)

Immunogenicity, safety and antibody persistence of a purified vero cell cultured rabies vaccine (Speeda) administered by the Zagreb regimen or Essen regimen in post-exposure subjects
door: Nianmin Shi, et al.
Gepubliceerd in: (2017-06-01)

Rabies post-exposure prophylaxis for a male with severe Henoch Schönlein purpura following rabies vaccination
door: Zheng-Gang Zhu, et al.
Gepubliceerd in: (2018-11-01)

Evaluation of the Efficacy of the Vaccine Production Process in Removing Residual Host Cell DNA from the Vero Cell Rabies Vaccine
door: Jia Li, et al.
Gepubliceerd in: (2024-12-01)

Immunogenicity and safety of inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children
door: Pornthep Chanthavanich, et al.
Gepubliceerd in: (2018-04-01)

A Randomized, Double-Blind, Controlled Phase III Clinical Trial to Evaluate the Immunogenicity and Safety of a Lyophilized Human Rabies Vaccine (Vero Cells) in Healthy Participants Aged 10–60 Years Following Essen and Zagreb Vaccination Procedures
door: Xiaohong Wu, et al.
Gepubliceerd in: (2023-08-01)

Active safety surveillance of rabies monoclonal antibody and rabies vaccine in patients with category III potential rabies exposureResearch in context
door: Gagandeep Kang, et al.
Gepubliceerd in: (2023-07-01)

Infection and Prevention of Rabies Viruses
door: Shiu-Jau Chen, et al.
Gepubliceerd in: (2025-02-01)

Development of mRNA rabies vaccines
door: Zixin Fang, et al.
Gepubliceerd in: (2024-12-01)

Purified Vero Cell Rabies Vaccine (PVRV, Verorab<sup>®</sup>): A Systematic Review of Intradermal Use Between 1985 and 2019
door: Thomas Moulenat, et al.
Gepubliceerd in: (2020-03-01)

Safety, immunogenicity and immune-persistence of a lyophilized human rabies vaccine (Vero cells) under Zagreb and Essen regimens: a randomized, open-label, controlled phase III clinical trial in healthy participants aged 10–60 years in China
door: Zhenzhen Liang, et al.
Gepubliceerd in: (2024-11-01)

Safety, immunogenicity of lyophilized purified vero cell cultured rabies vaccine administered in Zagreb and Essen regimen in post-exposure subjects: A post-marketing, parallel control clinical trial
door: Lei Zhang, et al.
Gepubliceerd in: (2021-08-01)

A STUDY OF THE ULTRASTRUCTURE OF THE SURFACE OF THE TRANSPLANTABLE LINE VERO CELLS INFECTED WITH THE RABIES VIRUS (RABV, LISSAVIRUS, RHABDOVIRIDAE)
door: S. V. Generalov, et al.
Gepubliceerd in: (2017-10-01)

Pre-marketing immunogenicity and safety of a lyophilized purified human diploid cell rabies vaccine produced from microcarrier cultures: a randomized clinical trial
door: Xingyu Zhou, et al.
Gepubliceerd in: (2019-04-01)

Immunogenicity and safety of purified vero cell-cultured rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in the healthy Chinese subjects: a randomized, double-blind, positive controlled phase 3 clinical trial
door: Heng Shen, et al.
Gepubliceerd in: (2021-02-01)

Efficacy of Purified Vero Cell Rabies Vaccine (PVRV) under the Zagreb Regimen in Iran
door: Pooneh Rahimi, et al.
Gepubliceerd in: (2014-08-01)

Rabies and rabies immunobiological preparations: vaccinations Pasteur to the contemporary biotechnology
door: E. G. Abramova, et al.
Gepubliceerd in: (2019-11-01)

Safety and immunogenicity of rabies vaccine (PVRV-WIBP) in healthy Chinese aged 10–50 years old: Randomized, blinded, parallel controlled phase III clinical study
door: Xiaoyuan Huang, et al.
Gepubliceerd in: (2023-01-01)

Safety and neutralizing rabies antibody in healthy subjects given a single dose of rabies immune globulin caprylate/chromatography purified
door: Hanna K, et al.
Gepubliceerd in: (2018-06-01)

Retrospective study of rabies epidemiology in Ukraine (1950-2019)
door: I. F. Makovska, et al.
Gepubliceerd in: (2020-03-01)

Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against reindeer rabies
door: Irina Matveeva, et al.
Gepubliceerd in: (2022-09-01)

Management of rabies
door: J. Weyer, et al.
Gepubliceerd in: (2019-07-01)

The Formation of the Eastern Africa Rabies Network: A Sub-Regional Approach to Rabies Elimination
door: Emily G Pieracci, et al.
Gepubliceerd in: (2017-07-01)

Atypical rabies encephalitis in a six-year-old boy: clinical, radiological, and laboratory findings
door: Sunil Karande, et al.
Gepubliceerd in: (2015-07-01)

A case of human rabies in the Urban Area of Ribeirão Preto, SP, Brazil
door: SILVA Jorgete M., et al.
Gepubliceerd in: (1997-01-01)

A case of human survival of rabies, South Africa
door: Jacqueline Weyer, et al.
Gepubliceerd in: (2016-07-01)

Antibody persistence upto 5 years after primary immunization and booster with an inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children
door: Weerawan Hattasingh, et al.
Gepubliceerd in: (2022-01-01)

Amino Acid Mutation in Position 349 of Glycoprotein Affect the Pathogenicity of Rabies Virus
door: Jun Luo, et al.
Gepubliceerd in: (2020-04-01)

Comparison of the immunogenicity and safety of the purified chick embryo cell rabies vaccine manufactured in India and Germany: A randomized, single blind, multicentre, phase IV clinical study
door: Gadey Sampath, et al.
Gepubliceerd in: (2017-07-01)

Factors related to vaccines for both patients exposed with rabies and dogs
door: Lam Quy Ngo, et al.
Gepubliceerd in: (2022-03-01)

Factors related to vaccines for both patients exposed with rabies and dogs
door: Lam Quy Ngo, et al.
Gepubliceerd in: (2022-03-01)

Letter to the editor: Safety and immunogenicity of a novel recombinant rabies vaccine
door: Anurag Agarwal, et al.
Gepubliceerd in: (2022-11-01)

MANAJEMEN INFEKSI RABIES BERISIKO TINGGI: STUDI KASUS TANPA SERUM ANTI-RABIES
door: Mahdika Ambarwaty, et al.
Gepubliceerd in: (2023-12-01)